Form 8-K

8-K — Amesite Inc.

Accession: 0001213900-26-045782

Filed: 2026-04-21

Period: 2026-04-20

CIK: 0001807166

SIC: 7372 (SERVICES-PREPACKAGED SOFTWARE)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ea0287089-8k_amesite.htm (Primary)

EX-99.1 — PRESENTATION MATERIALS (ea028708901ex99-1.htm)

GRAPHIC (ea028708901_ex99-1img1.jpg)

GRAPHIC (ea028708901_ex99-1img2.jpg)

GRAPHIC (ea028708901_ex99-1img3.jpg)

GRAPHIC (ea028708901_ex99-1img4.jpg)

GRAPHIC (ea028708901_ex99-1img5.jpg)

GRAPHIC (ea028708901_ex99-1img6.jpg)

GRAPHIC (ea028708901_ex99-1img7.jpg)

GRAPHIC (ea028708901_ex99-1img8.jpg)

GRAPHIC (ea028708901_ex99-1img9.jpg)

GRAPHIC (ea028708901_ex99-1img10.jpg)

GRAPHIC (ea028708901_ex99-1img11.jpg)

GRAPHIC (ea028708901_ex99-1img12.jpg)

GRAPHIC (ea028708901_ex99-1img13.jpg)

GRAPHIC (ea028708901_ex99-1img14.jpg)

GRAPHIC (ea028708901_ex99-1img15.jpg)

GRAPHIC (ea028708901_ex99-1img16.jpg)

GRAPHIC (ea028708901_ex99-1img17.jpg)

GRAPHIC (ea028708901_ex99-1img18.jpg)

GRAPHIC (ea028708901_ex99-1img19.jpg)

GRAPHIC (ea028708901_ex99-1img20.jpg)

GRAPHIC (ea028708901_ex99-1img21.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0287089-8k_amesite.htm · Sequence: 1

false

0001807166

2026-04-20

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date

of Report (Date of earliest event reported): April 20, 2026

Amesite

Inc.

(Exact

name of registrant as specified in its charter)

Delaware

001-39553

82-3431718

(State

or other jurisdiction

incorporation)

(Commission

File Number)

(IRS

Employer

Identification

No.)

607

Shelby Street

Suite

700 PMB 214

Detroit,

48226

(Address

of principal executive offices)

(Zip

Code)

Registrant’s

telephone number, including area code: (734) 876-8141

N/A

(Former

name or former address, if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.0001 per share

AMST

The

Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

7.01 Regulation FD Disclosure.

Amesite

Inc. (the “Company”) has prepared presentation materials (the “Presentation Materials”) that management intends

to use from time to time in presentations about the Company’s operations and performance. The Presentation Materials were posted

to the Company’s website on April 20, 2026. The Presentation Materials are furnished as Exhibit 99.1 to this Current Report on

Form 8-K.

The

information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is furnished and shall not be deemed to be “filed”

for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject

to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be

incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after

the date of this Current Report, regardless of any general incorporation language in any such filing.

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits

Exhibit

No.

Description

99.1

Presentation Materials

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

AMESITE

INC.

Date:

April 20, 2026

By:

/s/

Ann Marie Sastry, Ph.D.

Name:

Ann

Marie Sastry, Ph.D.

Title:

Chief

Executive Officer

EX-99.1 — PRESENTATION MATERIALS

EX-99.1

Filename: ea028708901ex99-1.htm · Sequence: 2

Exhibit

99.1

Q 4 2026 April 20 , 20 26 Shareholder Update empowering people with ai tools

FORWARD LOOKING STATEMENTS This presentation may contain “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. For such forward - looking statements, we claim the protection of the safe harbor for forward - looking statements contained in the Private Securities Litigation Reform Act of 1995. As used below and throughout this presentation, the words “we”, “us” and “our” may refer to Amesite individually or together with one or more partner companies, as dictated by context. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward - looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for and continued access to additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our Securities and Exchange Commission filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward - looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as may be required by law. The information contained herein is intended to be reviewed in its totality, and any stipulations, conditions or provisions that apply to a given piece of information in one part of this presentation should be read as applying mutatis mutandis to every other instance of such information appearing herein.

NurseMagic TM directly addresses documentation and audit pain for every non - acute care business, with our AI - native d . ocumentation and workflow platform.

Problem Non - Acute Care Is Under Pressure • Tightening margins from labor inflation, staffing shortages, reimbursement complexity • Legacy software friction with duplicate entry, manual checks, disconnected workflows • MARKET NEEDS MODERN INFRASTRUCTURE, NOT MORE LAYERS : a system that reduces overhead and supports how operators actually run.

MARKET SEGMENTS AND SIZES. TOTAL: $1.5T HOSPICE $29.9B $162.4B $173.6B U.S. Hospice Market U.S. Home Health U.S. Home Care Size 8 Market Size 4 Market Size 1 407K 1.4M 3.2M workers 9 workers 5 workers 2 8.5K 11.5K 35K U.S. businesses 10 U.S. businesses 6 U.S. businesses 3 1.6M 12M 15M U.S. patients 11 U.S. patients 7 U.S. patients 3 Sources: 1. 2. 3. 4. 5. 6. 7. 8. https:// www .ibisworld.com/unit ed - states/industry/home - care - providers/1579/ https:// www .phinational.org/policy - research/key - facts - faq/ https:// www .grandview research.com/industry - analysis/us - home - healthcare - market - report https://sagapixel.com/marketing/home - care - statistics/#:~:text=There%20are%20approximately% 2012%2C000%20M edicare,operating% 20outside%20of%20Medicare's %20purview . https:// www .statista.com/statistics/185249/persons - employed - in - home - health - care - services - in - the - us - since - 2000/#:~:text=In% 202023%2C% 20there%20were%20approximately,of%201.5%20million%20in%202016. https:// www .statista.com/statistics/1550572/number - of - home - health - agenc ies - in - the - us/ https://boosthomehealth.com/home - health - statistics/ https:// www .grandview research.com/industry - analysis/us - hospice - market 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. https:// www .ibisworld.com/united - states/employment/hospices - palliative - care - centers/4952/#:~:text=How%20many%20people%20are% 20employed,the% 20US%20as%20of%202023. https:// www .definitivehc .com/resources/healthcare - insights/number - of - hospice - organizations - by - state https://zipdo.co/hospice - statistics/ https:// www .grandview research.com/industry - analysis/us - skilled - nursing - facility - market https://fred.stlouisfed.org/series/CES6562310001 https:// www .definitivehc .c om/resourc es/healthcare - insights/skilled - nursing - facilities - us https:// www .ahcancal.org/Data - and - Research/facts/Pages/default.aspx https:// www .grandview researc h.com/industry - analysis/us - senior - living - market - report https:// www .ahcancal.org/Assisted - Living/Facts - and - Figures/Pages/default.aspx https:// www .seniorliving.org/companies/statistics/ SKILLED NURSING $199.7B U.S. Skilled Nursing Market Size 12 1.5M workers 13 16.6K U.S. businesses 14 4M U.S. patients 15 HOME CARE HOME HEALTH SENIOR LIVING $943.9B U.S. Senior Living Market Size 16 1.5M Workers 17 32.2K U.S. businesses 17 9.5M U.S. patients 18

MADISON NurseMagic Testimonials P O S I T I V E T E S T I M O N I A LS H A V E G R O W N A N D 5 S T A R R E VI E WS H A V E I N CR E A S E D . PU B L IC VIS IB I L IT Y O N B 2 C S A L E A L SO B O O S TS B 2 B S A L E S . 25 ratings What Our B2B Users Are Saying • “I purchased NurseMagic for my RN CMs, and it has been a night and day difference in getting documentation completed.” • “NurseMagic is a game - changer for me, my staff, and our caregivers.” • “My company started using NurseMagic just a couple of weeks ago. It has changed the way our nurses look at charting.” 2026 NURSEMAGIC HONORS

NurseMagic TM – DISRUPTIVE PRICING LARGE SCALE ORGANIZATION PRICING D ocu me n t at i o n : s tar t in g a t $ 1 / p at ien t / mo nth F u l l EMR : 50 - 80 % l e s s th an l e ga cy p rov id er s Pl a t for m : s ing l e p l a t form , m u l t ip l e ca re se t t in g s , mu l t ip l e p rofe ss ion a l s , mu l t ip l e l a n gu a ge s , m ulti ple loca t ion s Ou r AI - f i r st in f rastru cture e nab l es u s to g ain a marg in at a smal l fr act ion of what our c ur ren t comp etitor s c harg e cust om ers , wit h a s ingle p l a t fo rm . The y co me fo r d oc ume nta t i on. The y a r e in tere st ed in ful l er se rvi ces.

NurseMagic TM – Path to Profitability Products Segments Revenue & Targets 39% B2C, 61% B2B Q2 2026 A N T I C I P A T E P R O F I T A B I LI T Y A T ~ 1 0 - 2 0 NE W , L AR G E C U S T O ME R S OR L E S S TH AN $ 5 M / Y E A R I N R E VE N U E . AN T I C I P A T E 30 - 9 0 D AY S AL E S C Y C LE ( E N G A G E ME NT T O C LO S E ) B A S E D ON C U R R E N T P R O S P E C T S . Q3 2026 Q4 2026 B2B Segments Served – Home Care, Home Health, Hospice, Senior Living, Skilled Nursing 69% ↑ increase from prior quarter DOCUMENTATION and EMR. ONE PLATFORM. ACCESSIBLE PRICE. FULL AI END - TO - END SOLUTION. 46% B2C, 54% B2B B2B Segments Served – Home Care, Home Health, Hospice, Senior Living, Skilled Nursing TARGET: Home Care, Home Health, Hospice, Senior Living, Skilled Nursing, Palliative Care (census >5,000) TARGETED: Larger, multisite organizations (census >5,000) TARGET: WIN MULTI - SITE, MULTI - SEGMENT ORGANIZATIONS. NurseMagic Individual NurseMagic Teams NurseMagic Teams+ NurseMagic Enterprise NurseMagic AI Native EMR NurseMagic Personal NurseMagic Enterprise NurseMagic AI Native EMR

MILESTONES FEB 2024 NurseMagic Work Began APR 2024 B2C Beta Announced SEP 2024 B2B Pilots Announced DEC 2024 B2C Paid Announced FEB 2025 B2B Paid Announced SEP 2025 Announced 63% Revenue Growth July 14 to September 11, 2025 MAY 2025 Announced 240% Revenue Growth QoQ Q2 / 2026 Revenues = $108,050 JUL 2025 NurseMagic Enterprise Announced

OPPORTUNITY: Different Settings, Shared Structure Home Care Senior Living SNF Hospice Home Health Capability ض ض ض ض ض Required Documentation ض ض ض ض ض Clinical Documentation ض ض ض ض ض Non - Clinical Documentation ض ض EVV ض ض ض CMS / Federal Forms ض ض ض ض ض State Forms ض ض ض ض ض Payer Forms ض ض ض ض ض Internal Templates ض ض ض ض ض Billing Integration ض ض ض ض ض Regulatory Reporting ض ض ض ض ض Financial Reporting Segments: Clear Commonalty Market has a common structure with different required outputs. NurseMagic was built for the structure. One platform built on a shared data architecture — so new regulatory requirements become scalable configuration, not custom rebuilds.

Commercial Breadth – > Right Infrastructure PROVEN ACROSS DEAL TYPES • Clear value proposition – cost AND performance: broad commercial testing clarified recurring workflow and data requirements • Built for P&L impact : shared infrastructure around what repeats — documentation, compliance, billing - linked workflows, and reporting • High operating leverage: new customer requirements absorbed through a common platform architecture, supporting efficient deployment and lower marginal cost / complexity • Scalable ROI model : platform positioned to expand across segments without fragmenting the product or diluting the value proposition ORGANIZATIONS WITH MULTIPLE LOCATIONS CUSTOMERS WITH EXTREME AUDIT SENSITIVITY CUSTOMERS WITH EXTREME PRICE SENSITIVITY CUSTOMERS WITH MULTIPLE CARE SETTINGS – HOSPICE TO SENIOR LIVING

NurseMagic TM Infrastructure Enables Disruptive Pricing Don’t bring overhead to a margin fight. AI - First Infrastructure Single Source of Truth Efficient, Zero - Labor Deployment Modular, AI - native infrastructure & frameworks eliminate maintenance overhead and high costs of hodge - podge, legacy systems . NurseMagic structures all patient data around the plan of care – eliminating redundancy and reducing costly errors, support, and labor . Setup and data migration is automated – enabling ZERO setup fees and ZERO data transfer fees .

NurseMagic TM Brand Reach: B2C Built B2B Visability 49K+ F O L L O W E R S S I N C E F E B 2 0 2 4 I N C E P T I O N 6 S O C I A L C H A N N E L S M U LT I P L E VI R AL P OST S W I T H O V E R 1 M V I E W S 1.1M A C C O U N T S R E A C H E D I N L A S T 9 0 D A Y S H I GH V I SI B I L I T Y ON AI T OOL S W I T H M U L T I P L E C U S T O M E R S W H O H A V E F O U N D U S V I A C H A T G P T & O T H E R A I M O D E L S F U N C T I ON I N G B 2 C T O B 2 B P I P EL I N E W I T H M U L T I P L E B 2 C U S E R S W H O H A V E R E F E R R E D U S T O T H E I R W O R K P L A C E B 2 C Social Campaigns B 2 B Impact

NurseMagic TM Sales Pipeline Sales Marketing ~50K Prospects ~1K Organizations ~200K Prospects ~7K Organizations Sales & Marketing Signal Active Discussions 15 Organizations ~62,000 census EXAMPLES: Current Prospects Customer A: Census ~3,000 Multi - site • Multi - segment • High Audit Sensitivity • High Price Sensitivity Customer B: Census ~2,000 Multi - organization •Multi - segment • High Audit Sensitivity • High Price Sensitivity Customer C: Census ~35,000 Multi - segment • High Audit Sensitivity • High Price Sensitivity ~20K Avg. Daily Emails Opened ~10K Avg. Daily Email Clicks OUTREACH ENGAGEMENT

FINANCE

Nasdaq: AMST – Broader Opportunity • A profitable wedge could reframe AMST from application company  platform company • Shift expands strategic optionality: partnerships, JDs, tuck - in M&A, strategic combinations, potential acquisition interest • Operating model may continue to evolve: from product validation to disciplined capital allocation against repeatable, high - ROI adjacencies • Institutional relevance increases as the market sees operating leverage, reusable infrastructure, and a widening solution set — not a single - use tool Demonstrated profitability converts product proof into platform optionality.

Nasdaq: AMST Building Revenue: • B2B NurseMagic TM B2C Sales Launched and Generating Revenue • B2C NurseMagic TM Sales Demonstrated in Large and Growing Market • Strong marketing and sales outreach, strong pipeline ; anticipate tight, B 2 B sales cycle . • Good Liquidity • Zero Debt $1.2M Cash On Hand 6 Estimated months of burn on hand $0 Debt 4.5M Shares Outstanding $2.7M Total Revenue Since Inception As of December 31, 2025 3.2M Public Float

Team Experience and Award - Winning Culture MARKETING 9y of collective experience digital marketing • lead generation • paid advertising • social media • influencer relations • content creation • brand management • SEM • SEO • public relations • data analytics SALES 23y of collective experience U.S. and global enterprise sales • higher education sales • enterprise sales • nonprofit sales • healthcare sales • financial services sales ENGINEERING 50y of collective experience full stack coding • software engineering • software & cloud architecture • product engineering • cybersecurity • US & global compliance • data science • AI system design • natural language processing • optimization and performance tuning • app development • computational modeling • statistical data analysis FINANCE 33y of collective experience auditor • private and public experience • financial forecasts • M&A • corporate financial advising 1 9 E A R N E D W O R K P L A C E E X C E L L E N C E A W A R D S 8 O F T H E M N A T I O N A L WINNER 2023 WINNER 2023 WINNER 2023

Leadership & Board Barbie Brewer J. Michael Losh Gilbert S. Omenn, MD, Ph.D. George Parmer Dr. Ann Marie Sastry Founder, Chair & CEO • Former CEO and co - Founder of Sakti3 (acquired by Dyson in 2015 for $90M) • Recognized by President Obama at the White House in 2015 for her technology entrepreneurship • Featured in WSJ, Fortune, Forbes, The Economist, USA Today, The New York Times ; cover of Inc. • Arthur F. Thurnau Professor (UM’s highest teaching honor) at the University of Michigan, 17 years • >100 publications and 100 patents and filings. >100 invited lectures and seminars globally (NIH, NSF, NAE, MIT, Stanford, UC Berkeley, Oxford, Cambridge, etc.) • Boards of the International Council on Clean Transportation (ICCT), Oxford Companies • PhD and MS degrees from Cornell University, BS from the University of Delaware, Mech Engineering T E C H & H E A L T H C A R E F I N A N C E P E O P L E & G R O W T H

AMESITE INVESTMENT HIGHLIGHTS NurseMagic TM App Seeing Rapid Adoption, both B2C and B2B Closed Enterprise Deals with NurseMagic TM in $5.2B Industry Proven AI - Powered Higher Ed Platform That Runs Turnkey Targeting Sustainable Margins with Lean Operations – 50% reduction in SG&A in last FY Rapid Increase in Revenue Anticipated with B2B Sales in Large & Hungry Health Care Market No Corporate Debt & Good Liquidity Featured in Fox Business News, Yahoo!Finance, CNBC, Bloomberg, Forbes, Business Insider, and other publications CNBC Squawk Box Newsy Tonight

F O L L O W O U R P R O G R E S S THANK YOU

GRAPHIC

Filename: ea028708901_ex99-1img1.jpg · Sequence: 3

Binary file (768717 bytes)

Download ea028708901_ex99-1img1.jpg

GRAPHIC

Filename: ea028708901_ex99-1img2.jpg · Sequence: 4

Binary file (879034 bytes)

Download ea028708901_ex99-1img2.jpg

GRAPHIC

Filename: ea028708901_ex99-1img3.jpg · Sequence: 5

Binary file (659350 bytes)

Download ea028708901_ex99-1img3.jpg

GRAPHIC

Filename: ea028708901_ex99-1img4.jpg · Sequence: 6

Binary file (941675 bytes)

Download ea028708901_ex99-1img4.jpg

GRAPHIC

Filename: ea028708901_ex99-1img5.jpg · Sequence: 7

Binary file (681181 bytes)

Download ea028708901_ex99-1img5.jpg

GRAPHIC

Filename: ea028708901_ex99-1img6.jpg · Sequence: 8

Binary file (719531 bytes)

Download ea028708901_ex99-1img6.jpg

GRAPHIC

Filename: ea028708901_ex99-1img7.jpg · Sequence: 9

Binary file (666358 bytes)

Download ea028708901_ex99-1img7.jpg

GRAPHIC

Filename: ea028708901_ex99-1img8.jpg · Sequence: 10

Binary file (826419 bytes)

Download ea028708901_ex99-1img8.jpg

GRAPHIC

Filename: ea028708901_ex99-1img9.jpg · Sequence: 11

Binary file (386584 bytes)

Download ea028708901_ex99-1img9.jpg

GRAPHIC

Filename: ea028708901_ex99-1img10.jpg · Sequence: 12

Binary file (591754 bytes)

Download ea028708901_ex99-1img10.jpg

GRAPHIC

Filename: ea028708901_ex99-1img11.jpg · Sequence: 13

Binary file (826421 bytes)

Download ea028708901_ex99-1img11.jpg

GRAPHIC

Filename: ea028708901_ex99-1img12.jpg · Sequence: 14

Binary file (665890 bytes)

Download ea028708901_ex99-1img12.jpg

GRAPHIC

Filename: ea028708901_ex99-1img13.jpg · Sequence: 15

Binary file (661482 bytes)

Download ea028708901_ex99-1img13.jpg

GRAPHIC

Filename: ea028708901_ex99-1img14.jpg · Sequence: 16

Binary file (467959 bytes)

Download ea028708901_ex99-1img14.jpg

GRAPHIC

Filename: ea028708901_ex99-1img15.jpg · Sequence: 17

Binary file (310949 bytes)

Download ea028708901_ex99-1img15.jpg

GRAPHIC

Filename: ea028708901_ex99-1img16.jpg · Sequence: 18

Binary file (842846 bytes)

Download ea028708901_ex99-1img16.jpg

GRAPHIC

Filename: ea028708901_ex99-1img17.jpg · Sequence: 19

Binary file (424869 bytes)

Download ea028708901_ex99-1img17.jpg

GRAPHIC

Filename: ea028708901_ex99-1img18.jpg · Sequence: 20

Binary file (818552 bytes)

Download ea028708901_ex99-1img18.jpg

GRAPHIC

Filename: ea028708901_ex99-1img19.jpg · Sequence: 21

Binary file (624386 bytes)

Download ea028708901_ex99-1img19.jpg

GRAPHIC

Filename: ea028708901_ex99-1img20.jpg · Sequence: 22

Binary file (711477 bytes)

Download ea028708901_ex99-1img20.jpg

GRAPHIC

Filename: ea028708901_ex99-1img21.jpg · Sequence: 23

Binary file (594334 bytes)

Download ea028708901_ex99-1img21.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 28

v3.26.1

Cover

Apr. 20, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 20, 2026

Entity File Number

001-39553

Entity Registrant Name

Amesite

Inc.

Entity Central Index Key

0001807166

Entity Tax Identification Number

82-3431718

Entity Incorporation, State or Country Code

Entity Address, Address Line One

607

Shelby Street

Entity Address, Address Line Two

Suite

700 PMB 214

Entity Address, City or Town

Detroit

Entity Address, State or Province

Entity Address, Postal Zip Code

48226

City Area Code

734

Local Phone Number

876-8141

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, par value $0.0001 per share

Trading Symbol

AMST

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration